Newsroom
Keep up with the latest
Featured
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025
November 17, 2025
Epigenetic editors are a gentler form of gene editing
February 24, 2025
The Economist
Epigenetic editors are a gentler form of gene editing
February 24, 2025
Media Center
Media
Scribe: engineering CRISPR’s next generation
October 6, 2020
BioCentury
Read Now
Press Release
Scribe: engineering CRISPR’s next generation
October 6, 2020
BioCentury
Read Now
Media
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter
October 6, 2020
BioXconomy
Read Now
Press Release
Scribe Therapeutics Sets Out to Write CRISPR Gene Editing’s Next Chapter
October 6, 2020
BioXconomy
Read Now
Media
Doudna Inc.: How Cal scientist created a biotech startup engine
October 6, 2020
San Francisco Business Times
Read Now
Press Release
Doudna Inc.: How Cal scientist created a biotech startup engine
October 6, 2020
San Francisco Business Times
Read Now
Media
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
October 6, 2020
Endpoints News
Read Now
Press Release
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
October 6, 2020
Endpoints News
Read Now